Author

M. M. Cleary

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

C. A. Keller· 1 shared C. A. Ricker· 1 shared G. A. Li· 1 shared H.-I. H. Chen· 1 shared J. F. Shern· 1 shared K. A. Crawford· 1 shared M. N. Svalina· 1 shared N. E. Berlow· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. A. Keller

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 28, 2019

MEK1/2 in Rhabdomyosarcoma

K. A. Crawford, M. M. Cleary, C. A. Ricker…·G. A. Li

This study evaluates the combination of MEK inhibitor cobimetinib and chemotherapy in rhabdomyosarcoma, finding no significant additive or synergistic effects and potential antagonistic effects on chemotherapy efficacy.

DOI 10.1101/629766

humanbulk RNA-seq

𝕏 PostBluesky